Clinical outcome following checkpoint therapy in renal cell carcinoma is associated with a burst of activated CD8 T cells in blood - Concepedia

Concepedia

Publication | Open Access

Clinical outcome following checkpoint therapy in renal cell carcinoma is associated with a burst of activated CD8 T cells in blood

DOI Full Paper Access

35

Citations

48

References

2022

Year

Jennifer W. Carlisle, Caroline S. Jansen, Maria A. Cardenas, Ewelina Sobierajska, Adriana Moon Reyes, Rachel Greenwald, Luke del Balzo, Nataliya Prokhnevska, Ömer Küçük, Bradley Curtis Carthon,

Journal for ImmunoTherapy of Cancer

Abstract

Together, these data suggest that having a strong pre-existing immune response and immediate peripheral T-cell activation after checkpoint therapy is a predictor of clinical benefit in patients with RCC.

References

	Year	Citations

Page 1